Antiretroviral Drugs as the Linchpin for Prevention of HIV Infections in the United States
Am J Public Health
.
2017 Oct;107(10):1577-1579.
doi: 10.2105/AJPH.2017.304011.
Authors
Taraz Samandari
1
,
Norma Harris
1
,
Janet C Cleveland
1
,
David W Purcell
1
,
Eugene McCray
1
Affiliation
1
All of the authors are with the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
PMID:
28902548
PMCID:
PMC5607687
DOI:
10.2105/AJPH.2017.304011
No abstract available
Publication types
Editorial
MeSH terms
Anti-Retroviral Agents / therapeutic use*
HIV Infections / drug therapy*
HIV Infections / prevention & control*
Humans
Public Health
United States
Substances
Anti-Retroviral Agents
Grants and funding
CC999999/Intramural CDC HHS/United States